Hippos, LLC's Cultivation and Manufacturing Division OG Yields Introduces Cannabis Brand ‘Hugs'
New Product Line to Provide Relief and Comfort to Missouri's Medical & Recreational Cannabis Communities
VIENNA, MO - February 12, 2025 ( NEWMEDIAWIRE) - Hippos, LLC, Missouri's premier cannabis company with retail locations statewide and award-winning brands produced by its OG Yields division, is proud to announce the launch of its newest brand, Hugs. With a profound commitment to improving the lives of individuals seeking relief from daily discomfort, Hugs is poised to revolutionize the cannabis landscape in the state of Missouri. Hugs, with its poignant tagline 'Hugs Help,' represents more than just a product line; it embodies compassion, support, and a dedication to wellness.
The Hugs line launches with its new line of THC-containing topical products, specifically formulated to provide localized relief without any psychoactive effects. Unlike THC products that are ingested or inhaled, which enter the bloodstream and can produce a psychoactive 'high,' Hugs topicals are applied directly to the skin. When applied this way, THC interacts with receptors in the skin, but does not reach the bloodstream in significant amounts. This means that the topical is able to provide targeted relief without affecting mental clarity or cognition. Whether consumers are looking for relief after a workout, to soothe localized discomfort, or to care for their skin, Hugs topicals product line offers a soothing non-intoxicating option.
As part of the brand launch, Hippos is introducing its meticulously crafted Cannabis Salve, a harmonious blend of emu oil, THC, and essential oils designed to support not just relief but a holistic approach to skin health and discomfort.
Hugs Cannabis Salve Ingredients and Benefits:
'At Hippos Cannabis, we believe in the transformative power of cannabis to enhance lives and alleviate discomfort,' said Nicholas Rinella, CEO of Hippos Cannabis. 'With Hugs, we're extending our commitment to serving the diverse needs of Missouri's cannabis industry by offering high-quality products designed to provide comfort and relief in their daily lives.'
Whether you're dealing with life's everyday challenges or simply seeking balance, Hugs provides a natural, plant-based option that may provide relief. Hugs will continue to expand its product offering throughout 2025, introducing new solutions to address the evolving needs of Missouri's cannabis industry.
The dynamic new brand is available for purchase at all Hippos' dispensary locations, marking a significant milestone in Hippos' mission to redefine the standards of quality and care.
About Hippos, LLC
Hippos, LLC is committed to promoting the powerful benefits of cannabis and related products while also prioritizing sustainability to support current and future generations. Hippos, LLC operates dispensaries in Chesterfield, Columbia and Springfield under the name 'Hippos Marijuana Dispensary;' a cultivation and manufacturing facility under the name 'OG Yields;" and has developed brands such as the award-winning 'Sundro,' 'Atta', 'Bad Pony' and 'Hugs' that are available throughout Missouri for purchase. Hippos is home to the award-winning Brett Hull #16 cannabis strain, and continues to be on the forefront of innovations in concentrate formulations and related technologies. Founded in 2019, Hippos is a recognized champion of patient and adult use access and education initiatives in the state. Stay up-to-date with Hippos at hipposcannabis.com as well as on Instagram, at @hipposcannabis, @attacannabis, @sundrolife, @badponycannabis, and @ogyields.
Public Relations Contact
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Yahoo
2 hours ago
- Yahoo
Cucumbers grown in Florida linked to outbreak of salmonella. What you should know
Cucumbers grown in Florida have been linked to an outbreak of salmonella. TGD Cuts, LLC of Jessup, Maryland, recalled salsa and cucumber products because they were made with cucumbers that are possibly contaminated with salmonella. The recalled items contained cucumbers from Boynton Beach, Florida-based Bedner Growers Inc. Here's what you need to know about the latest recall. TGD Cuts, LLC of Jessup, Maryland, recalled some tub and tray products because they contained cucumbers from Bedner Growers Inc. of Florida. The cucumbers have been linked to a salmonella outbreak. TGD Cuts distributed the affected products, which included salsas, sliced cucumbers and cucumber spears, to retail and foodservice locations in Maryland, Virginia, Pennsylvania, New Jersey, and North Carolina, according to the Food and Drug Administration. Bedner Growers Inc. of Boynton Beach, voluntarily recalled cucumbers sold at Bedner's Farm Fresh Market and distributed by Fresh Start Produce Sales, Inc., the Centers for Disease Control and Prevention said in a release May 19. ➤ Florida cucumber recall triggers dozens of salad, sushi recalls from Walmart, Publix, more The cucumbers were sold at three Bedner's Farm Fresh Market locations in Boynton Beach, Delray Beach, and West Palm Beach between April 29, 2025, and May 14, 2025, according to a release from the U.S. Food and Drug Administration. As of May 23, there have been 26 reported salmonella cases, the CDC said, in 15 states, including Florida. "Several people ate cucumbers on cruise ships leaving ports in Florida," the CDC said. In June 2024, Fresh Start Produce Sales Inc. recalled cucumbers from Bedner and from Thomas Produce Co. of Boca Raton that were linked to a salmonella outbreak that sickened 551 people in 34 states and the District of Columbia, including 60 people in Florida. Tomatoes distributed in three southern states — none in Florida — became the subject of a possibly deadly recall, according to the Food and Drug Administration. Williams Farms Repack LLC, based in Lodge, South Carolina, said the affected tomatoes were packaged and sold to wholesalers and distributors between April 23-28 under the name H&C Farms Label. On June 6, the CDC and FDA linked brown eggs sold in nine states — including at some Walmart stores — to an ongoing salmonella outbreak in which 79 people have been sickened and at least 21 hospitalized. "Salmonella are bacteria that make people sick," the Centers for Disease Control and Prevention said. Contaminated food is the source for most of these illnesses. Children younger than 5, adults 65 and older, and people with weakened immune systems are more likely to have severe illness. Pregnant women are also at higher risk of developing an infection from it and should seek medical attention if symptoms arise. Salmonella bacteria cause "about 1.35 million infections, 26,500 hospitalizations, and 420 deaths in the United States every year," the CDC said. Freezing and drying do not kill salmonella, the FDA said. Cooking will kill bacteria, including salmonella, but you'll need to use a food thermometer to make sure the temperature gets between 145 and 165 degrees, depending on what you're cooking. Be careful of all surfaces and your hands to prevent cross-contamination. ➤ Safe food temperature chart Salmonella can make people ill with diarrhea, fever, and stomach cramps, which can last from four days up to a week. Symptoms usually begin six hours to six days after infection, the CDC said. Most cases of salmonella infections pass, but some people may need to be hospitalized. Symptoms include: Feeling dizzy when standing up Diarrhea and a fever higher than 102 degrees Diarrhea for more than 3 days that is not improving Bloody diarrhea So much vomiting that you cannot keep liquids down Signs of dehydration, such as: Not urinating much Dry mouth and throat Contributing: C.A. Bridges, USA Today Network- Florida This article originally appeared on Treasure Coast Newspapers: Food recalls: Cucumbers grown in Florida, salsa, tomatoes, eggs
Miami Herald
3 days ago
- Miami Herald
Americans lose it over these tiny everyday annoyances
Simply spotting a nemesis, loud chewing and heavy breathing are some of the smallest things that will push Americans over the edge, according to new research. A survey asked 2,000 adults about their lowest common denominator of stress and revealed that the smallest sounds or acts are enough to send their anxiety skyrocketing. Lagging WiFi (40%) and an unexpected phone call (35%) also ranked high on the list. Americans outlined some of the weirdest causes of stress: "the texture of my socks," "aluminum cans," "not washing my hair for two days" and "the beeping sound on TV to hide swearing" were among the most unique. To pile on, just thinking about how expensive everything has gotten (47%), running late when stuck in traffic (40%) and simple miscommunications (39%) are common stressful situations. Conducted by Talker Research on behalf of CBDfx, results also revealed what Americans do when they need to mellow out. Many turn to music (58%), deep breathing and meditation (34%) or pet cuddles (32%). In fact, Americans would rather hear their favorite artist or band over their partner (46% vs 34%) when they need to de-stress. The average American has stuck to their unwinding method for over a decade, which may be because 84% find these approaches effective. The survey, which polled respondents who have all tried CBD or THC before, also found that 20% take CBD gummies and 30% use THC products on a daily basis in order to combat their stress. And it's working: Users find that their stress levels are decreased by an average of 54% after taking a CBD gummy, while THC users find they drop by more than two-thirds (68%). Nearly three in five (58%) respondents believe that there's less stigma surrounding CBD and THC products today, compared to 10 years ago. But compared to just five years ago, two-thirds (67%) find themselves getting stressed easier. This may be why another two-thirds (67%) agree that Americans would be less stressed out if they all indulged in some CBD or THC. "One of the benefits of CBD's interaction with the body's endocannabinoid system is a calming effect that works great for dialing down stress," said Jameson Rodgers, CBDfx Co-Founder. "THC can have similar positive effects-enhanced by the compound's natural mood elevation benefits-making it another great choice for stress relief." Seventy-three percent of Americans say that stress has an impact on their quality of life and an even larger number (77%) said it has an impact on their quality of sleep. In fact, only 20% of Americans admit they don't look at their phone past a certain time each night and even fewer (11%) avoid looking at it before a certain time in the morning. To combat this, the average respondent takes CBD gummies an average of three nights a week, while 16% say it's a nightly occurrence. They also average using THC products four nights each week, with 29% doing so nightly. "Over time, lack of sleep can have a negative effect on many areas of a person's overall health, including stress. When you're tired, stress can be more difficult to manage and, potentially, can do more long-term damage," said Rodgers. "CBD sleep products can be an effective natural sleep aid. Those same calming effects that make CBD great for stress relief also make it an effective base ingredient for sleep aids, along with compounds like CBN (cannabinol), melatonin, chamomile, and other natural ingredients. THC works well with those same natural sleep ingredients, helping to elevate one's mood and help them relax before bedtime." TOP 10 SMALLEST THINGS/SOUNDS THAT CAUSE AMERICANS STRESS When I see someone that I don't want to talk to - 46%A knock on the front door when I'm not prepared for guests - 44%People talking to me when I want silence - 43%When my Wi-Fi is lagging or cuts out - 40%Listening to someone chewing loudly - 40%Phone calls when I'm not expecting one - 34%Someone near me heavy breathing - 25%My alarm clock/alarm - 21%Text message alerts - 16%My phone/notifications going off during a meeting - 15% Survey methodology: Talker Research surveyed 2,000 Americans who've ever tried CBD or THC; the survey was commissioned by CBDfx and administered and conducted online by Talker Research between April 30 and May 8, 2025. We are sourcing from a non-probability frame and the two main sources we use are: Traditional online access panels - where respondents opt-in to take part in online market research for an incentiveProgrammatic - where respondents are online and are given the option to take part in a survey to receive a virtual incentive usually related to the online activity they are engaging in Those who did not fit the specified sample were terminated from the survey. As the survey is fielded, dynamic online sampling is used, adjusting targeting to achieve the quotas specified as part of the sampling plan. Regardless of which sources a respondent came from, they were directed to an Online Survey, where the survey was conducted in English; a link to the questionnaire can be shared upon request. Respondents were awarded points for completing the survey. These points have a small cash-equivalent monetary value. Cells are only reported on for analysis if they have a minimum of 80 respondents, and statistical significance is calculated at the 95% level. Data is not weighted, but quotas and other parameters are put in place to reach the desired sample. Interviews are excluded from the final analysis if they failed quality-checking measures. This includes: Speeders: Respondents who complete the survey in a time that is quicker than one-third of the median length of interview are disqualified as speedersOpen ends: All verbatim responses (full open-ended questions as well as other please specify options) are checked for inappropriate or irrelevant textBots: Captcha is enabled on surveys, which allows the research team to identify and disqualify botsDuplicates: Survey software has "deduping" based on digital fingerprinting, which ensures nobody is allowed to take the survey more than once It is worth noting that this survey was only available to individuals with internet access, and the results may not be generalizable to those without internet access. The post Americans lose it over these tiny everyday annoyances appeared first on Talker. Copyright Talker News. All Rights Reserved.
Yahoo
3 days ago
- Yahoo
Texas reined in recreational THC for more medical marijuana this legislative session
Texas lawmakers this year heavily focused their drug policy agenda on banning tetrahydrocannabinol, or THC, products in the state. Senate Bill 3, which prohibits the possession of consumable hemp products that contain any synthetic cannabinoid, often known as delta-8, was a priority for Lt. Gov. Dan Patrick, who often denounced the effects of the drug on children. As a concession of sorts to veterans and THC users with chronic conditions, House Bill 46 also passed, expanding the state's medical marijuana program by providing more products to users and adding more qualifying conditions. Both bills found themselves tied together as lawmakers reasoned that removing hemp options from the general public could be offset by expanding the medical marijuana industry. While the focus was primarily on THC this session, Texas quietly passed Senate Bill 2308, which would create a state-funded consortium to research a psychedelic drug called ibogaine. The clinical trials would test whether ibogaine is a viable treatment for substance use disorders and other mental health conditions. However, multiple bills that could have prevented overdose deaths failed to gain traction this year. House Bill 1644, for example, would have removed testing strips for fentanyl and xylazine, a veterinary sedative also known as 'tranq,' from the list of banned drug paraphernalia. In 2019, Texas lawmakers embraced the potential to boost the state's agricultural market by legalizing hemp products derived from cannabis plants with less than 0.3% of THC. Six years later, SB 3 intends to shut down the $8 billion hemp industry and cut its estimated 50,000 jobs when the ban takes effect in September. Critics say the hemp industry has exploited a loophole in the 2019 law to the tune of more than 8,000 retailers now selling THC-laced edibles, drinks, vapes, and flower buds. The proposed law would ban consumable hemp products that contain any synthetic cannabinoid, often known as delta-8. Non-intoxicating and non-psychoactive CBD or CBG would remain legal. People found in possession of a product with those intoxicating cannabis compounds could face a fine of up to $500. Higher fines and jail time would be possible for repeat offenders. Hemp industry leaders and advocates have denied any harmful intentions and are in favor of regulations on the industry rather than a ban. Aging Texans, veterans, and parents of children with mental illness or special needs have spoken out about the benefits of hemp, including the ease of access, the variety of products available to them, and the lower price. In contrast, concerned parents demanded a ban because they fear children would be harmed from recreational use. The Texas Hemp Business Council reported that it delivered 5,000 letters to Abbott's office earlier this week, along with a petition signed by over 120,000 people, urging the governor to veto the bill. Abbott has until June 22 to decide on a veto. In Texas, licensed medical cannabis providers must house all operations — including cannabis cultivation, processing, extracting, manufacturing, testing, and dispensing — under one roof. State regulations also prohibit inventory storage of medical cannabis products in multiple locations, so products must be distributed from the central dispensary. Any prescriptions scheduled for pickup outside the central dispensary must be driven daily to and from the pickup location — sometimes hundreds of miles round-trip. This has made their products more expensive and limited where the medical marijuana program can reach, hampering the small medical cannabis market in Texas. HB 46 aims to help by expanding the program to include more popular products such as prescribed inhalers and vaping devices, allow off-site storage and add nine dispensers, bringing the total to 12. It also adds traumatic brain injuries, chronic pain, Crohn's disease, and terminal illnesses to the list of qualifying conditions. The first three dispensers will be selected from the previously submitted 2015 list of dispensers and then made available to the public. The expansion of the medical marijuana program will go into effect in September if Abbott signs it into law. Among drug-related bills that received less attention was SB 2308, which will make Texas a hub for ibogaine-related research, development, treatment, manufacturing, and distribution. This will be accomplished by creating a consortium that includes higher education institutions, drug developers, nonprofits, and other stakeholders to secure U.S. Food and Drug Administration approval for a treatment. Ibogaine is a psychedelic found in the roots of the iboga plant, primarily found in Africa, and has been used for centuries during shamanistic rituals due to its ability to induce hallucinations in large doses. The drug has been illegal in many countries, but scientists recently announced a study finding that, in low doses, ibogaine might have beneficial uses to treat addiction, PTSD, and brain injuries. The bill could essentially give Texas a stake in any future revenue that may come from the state developing a medical use for ibogaine. The program will be funded through a $50 million appropriation from the state's general fund. Fentanyl, a potent drug commonly mixed with other substances and has caused the deaths of more than 7,000 Texans in the last six years, is odorless and tasteless, making detection nearly impossible without specialized equipment. Fentanyl test strips are among the cheapest and easiest ways to prevent overdoses, but for a third time, legislation to legalize them failed in the Senate. HB 1644, which would have legalized opioid drug testing strips, never got a hearing in the Senate despite passing unanimously in the House. The main argument against drug testing strips has been that it encourages continued drug use, but advocates deny this claim, saying that once someone is thinking about their safety, it is by the time they are getting close to quitting. Senate Bill 1732, which would have allowed nurses and physician assistants to prescribe medication-assisted treatment, like methadone and buprenorphine, for opioid use disorders, also never received a committee hearing. A smaller step lawmakers made to address overdoses comes in House Bill 4783, which requires the Texas Health and Human Services Commission to prepare a report every two years for lawmakers to evaluate the distribution of opioid overdose reversal drugs, like Narcan. The report will be required to create a statewide goal for opioid reversal drugs and include an estimate of insufficiencies in the current supply and a plan to address overdoses in high-risk areas.
